Allworth Financial’s Starling Oncology STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.7K Sell
744
-194
-21% -$1.16K ﹤0.01% 4473
2026
Q2
$5.09K Buy
938
+830
+769% +$3.49K ﹤0.01% 4113
2026
Q1
$332 Buy
108
+50
+86% +$153 ﹤0.01% 4824
2025
Q4
$207 Buy
58
+54
+1,350% +$200 ﹤0.01% 4696
2025
Q3
$14 Buy
+4
New +$14 ﹤0.01% 4849

Other funds holding STLN

Allworth Financial's STLN Position: Q3 2026 in Review

Allworth Financial reduced its Starling Oncology (STLN) stake by 21% in Q3 2026, selling an estimated $1.16K and leaving 744 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4473.

Allworth Financial first reported a position in STLN in Q3 2025 and has held it in 5 quarters since. The position peaked at $5.09K in Q2 2026. 129 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • Allworth Financial held 744 shares of Starling Oncology worth $4.7K as of Q3 2026.
  • Allworth Financial sold 194 Starling Oncology shares in Q3 2026, an estimated $1.16K.
  • Starling Oncology made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4473 holding.
  • Allworth Financial first reported a position in Starling Oncology in Q3 2025 and has held it in 5 quarters since.
  • Allworth Financial's Starling Oncology position peaked at $5.09K in Q2 2026.
  • 129 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.